Cell and Gene Therapy 25/06/2019 Technology Review: Gene Editing Edition one of Phacilitate’s technology review series examines gene editing approaches by viral and non-viral methods and where to access ...
Cell and Gene Therapy 25/06/2019 The Next Chapter Starts Here and Ends with a Cure Episode two with Nicole Gularte, Patient Advocate, Fight for Cures
Cell and Gene Therapy 23/06/2019 Patient Access and Delivery of Advanced Therapies - Part Two An interview with Dr Matthew Frigault, Instructor and Clinical Assistant in Medicine, Massachusetts General Hospital
Cell and Gene Therapy 20/06/2019 The Power of Perseverance: How Dendreon Bounced Back Episode one with Dwayne Soisson, Senior Director Operations, Dendreon
Cell and Gene Therapy 30/05/2019 ASGCT 2019: Patients are Top Priority Amanda Kendall, Phacilitate's Head of Community, gives her first-hand account of ASGCT 2019
Cell and Gene Therapy 28/05/2019 Are We Ready for a $5m Gene Therapy? Episode two of the Phacilitate Leaders World super plenary sessions with Dave Lennon, President of AveXis, Inc
Cell and Gene Therapy 28/05/2019 Advanced Therapies: Cost-effective but Unaffordable? Episode three of the Phacilitate Leaders World super plenary sessions with Michael Meyers, Head of Investment Banking at T.R. Winston ...
Cell and Gene Therapy 24/05/2019 Uncovering Innovation: Phacilitate’s Trip to Israel Phacilitate's Jeremy Roden and David Green ventured out to Tel Aviv to lift the lid on the biotech and advanced therapies innovation across the...
Cell and Gene Therapy 20/05/2019 Five Take-aways from the Advanced Therapies Network Investment Event Phacilitate's Kim Barnes gives her account of the Advanced Therapies Network investment meeting in London
Cell and Gene Therapy 13/05/2019 60 seconds with...Jeff Robertson, Charter Medical Charter Medical's President on automation and tubing standardisation
Cell and Gene Therapy 08/05/2019 Patient Access and Delivery of Advanced Therapies - Part One An interview with Jacqueline Barry, Chief Clinical Officer at Cell and Gene Therapy Catapult
Cell and Gene Therapy 07/05/2019 60 seconds with...Philip Wills, Paragon Bioservices Paragon Bioservice's Chief Commercial Officer on being acquired by Catalent and the future of the contract manufacturing landscape
Cell and Gene Therapy 01/05/2019 [WEBINAR] Standardization and Large-scale Manufacturing of Helper... Learn more about the background of helper plasmids, their application, regulatory considerations and advantages. Hosted by Aldevron.
Cell and Gene Therapy 23/04/2019 The Patient’s Eye View of the Kymriah® Story Episode one of the Phacilitate Leaders World super plenary sessions, led by Anthony Davies, Dark Horse Consulting
Cell and Gene Therapy 16/04/2019 Keeping up with the pace of technology in an evolving field of... Alberto Santagostino, Lonza Pharma & Biotech's SVP Cell and Gene Technologies delivers a keynote presentation at Phacilitate Leaders World 2019...
